Skip to main content

Promoting System Changes through Education, Surveillance and Policy to Advance Cancer Genomics Best Practices in Michigan, 2014-2019

Previous MDHHS-CDC cooperative agreements:
        • 2008 - 2011
        • 2011 - 2014

The MDHHS Cancer Genomics Program is building upon existing partnerships, policy interventions, health surveillance, and education to advance cancer genomics best practices in Michigan. The 2014-2019 cooperative agreement with the Centers for Disease Control and Prevention (CDC) aims to promote the adoption of cancer genomics best practices for Hereditary Breast and Ovarian Cancer (HBOC) and Lynch Syndrome (LS). The long-term goal is to reduce the incidence and mortality of hereditary cancers, especially breast cancer at a young age, ovarian cancer, endometrial cancer, and colorectal cancer.

The program strives to accomplish Healthy People 2020 (HP2020) Objectives to:

  1. Increase the proportion of women with a family history of breast and/or ovarian cancer who receive genetic counseling
  2. Increase the proportion of persons with newly diagnosed colorectal cancer who received genetic testing to identify Lynch syndrome
  3. Reduce the overall cancer death rate
  4. Reduce the female breast cancer death rate
  5. Reduce late-stage female breast cancer

Methods

The core project team consists of the program director, section managers, epidemiologist, evaluator, project assistant, contract managers, public/provider educator, and policy/health system educator. A Steering Committee, comprised of national, state, clinical, academic, and patient partners provides guidance on program activities. Key partners assist us in developing and expanding the following:

  1. System and policy initiatives to promote increased use of recommended cancer genomics best practices and improve access to care;
  2. Surveillance systems on hereditary cancers and use of cancer genomics best practices for hereditary breast and ovarian cancer (HBOC) and Lynch syndrome (LS);
  3. Educational opportunities for the public and health care providers on hereditary cancers and cancer genomics best practices;
  4. Partnerships necessary to accomplish all outcomes.

The project promotes the following evidence-based guidelines related to hereditary cancer: 

The target population encompasses the entire state of Michigan, especially patients and providers in counties with a high incidence of breast cancer at a young age, ovarian cancer, endometrial cancer, and colorectal cancer, and that lack cancer genetic services.

 State Resources

 

National Resources

 

Contact Us

If you have questions, call the MDHHS Genetic Information Line at 1-866-852-1247 or email genetics@michigan.gov

Genomics and Genetic Disorders Section 
Lifecourse Epidemiology and Genomics Division 
P.O. Box 30195
333 S. Grand Avenue
Lansing, Michigan  48909-30195

 Cancer Genomics Home Page

 

Funding for this program was made possible (in part) by the Centers for Disease Control and Prevention. The views expressed in written materials, publications, or webpages do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Last updated: 6/23/2022